)
Visual
test
Cinclus Pharma
Cinclus Pharma (CINPHA) investor relations material
Cinclus Pharma KOL Event summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.KOL Event summary11 Dec, 2025
Introduction and agenda
Event focused on linaprazan glurate, a next-generation PCAB, and its role in addressing unmet needs in GERD, especially severe erosive GERD.
Agenda included a KOL overview of GERD, limitations of current therapies, real-world patient cases, and a commercial landscape discussion.
KOL background and credentials
Dr. Prateek Sharma, Professor of Medicine, is internationally recognized for advancing GI disease management and has over 550 publications in top journals.
He is a frequent speaker at major scientific meetings and has contributed to clinical guidelines and textbooks.
Market insights and analysis
GERD affects about 20% of the U.S. population and 14% globally, with significant impact on quality of life and work productivity.
Erosive GERD, especially grades C and D, is associated with higher risks of complications like Barrett's esophagus and esophageal cancer.
The severe erosive GERD market in the USA and Europe is estimated at 10 million patients, representing a large, dynamic, and chronic market with frequent drug switching.
PCABs are gaining traction globally, with premium pricing and rapid uptake in markets like Japan and the U.S.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 5 FebDG
Record free cash flow and broad-based earnings growth drive strong 2025 results and positive 2026 outlook. - 5 FebMOD
Q3 FY26 sales up 31%, strong data center growth, pension charge led to net loss, major spin-off announced. - 5 FebAPOLLOTYRE
Record revenue, profit growth, major expansion, and improved financial metrics in Q3 FY26. - 5 FebCMI
Record 2025 results, $458M Accelera charges, and 2026 growth led by data center power. - 5 FebHP
EBITDA $230M, $1.02B revenue, net loss $97M, $260M debt repaid, strong tech rollout. - 5 FebNOV
Q4 2025 revenue up 5% sequentially, strong cash flow, 2026 outlook cautious but improving. - 5 FebGL
Earnings and premium growth drive strong results, higher 2026 guidance, and ongoing share buybacks. - 5 FebRRX
Q4 orders up 53.8% with $735M E-Pod win; 2026 EPS guidance up ~10%. - 5 FebSNA
Q4 sales up 2.8%, EPS at $4.94, strong cash, and a notable building sale gain. - 5 FebRBC
Q3 sales rose 17% with strong A&D growth, high cash flow, and record $2.1B backlog.
Next Cinclus Pharma earnings date
Q4 202518 Feb, 2026
Cinclus Pharma
Next Cinclus Pharma earnings date
Q4 202518 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Cinclus Pharma Holding AB is a clinical-stage pharmaceutical company based in Stockholm, Sweden. The company specializes in the development of treatments for acid-related diseases. Its primary focus is on a drug candidate called linaprazan glurate, which is being developed for the treatment of gastroesophageal reflux disease (GERD) and Helicobacter pylori infections. Linaprazan glurate is designed as a Potassium-Competitive Acid Blocker (P-CAB), offering a potentially more effective alternative to traditional Proton Pump Inhibitors (PPIs) used in treating acid-related conditions. Cinclus Pharma Holding AB is headquartered in Stockholm, Sweden, and its shares are listed on the Nasdaq Stockholm.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage